Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Hepatic steatosis is a major feature associated with NAFLD (non-alcoholic fatty liver disease). The aims of the present study were to assess the levels of PUFA (polyunsaturated fatty acids) in liver total lipids, triacylglycerols (triglycerides) and phospholipids of NAFLD patients in relation to those in adipose tissue and hepatic indexes related to oxidative stress as factors contributing to hepatic steatosis. Eleven control subjects and 19 patients with NAFLD were studied. Analysis of liver and abdominal adipose tissue fatty acids was carried out by GLC. The liver content of protein carbonyl groups and malondialdehyde were taken as indexes related to oxidative stress. NAFLD patients had a depletion in LCPUFA (long-chain PUFA) of the n-6 and n-3 series in liver triacylglycerols, with decreased 20:4,n-6/18:2,n-6 and (20:5,n-3+22:6,n-3)/18:3,n-3 ratios, whereas liver phospholipids contained higher n-6 and lower n-3 LCPUFA. These findings were accompanied by an enhancement of (i) n-6/n-3 ratio in liver and adipose tissue, (ii) 18:1,n-9 trans levels in adipose tissue, and (iii) hepatic lipid peroxidation and protein oxidation indexes. It is concluded that a marked enhancement in LCPUFA n-6/n-3 ratio occurs in the liver of NAFLD patients, a condition that may favour lipid synthesis over oxidation and secretion, thereby leading to steatosis. Depletion of hepatic LCPUFA may result from both defective desaturation of PUFA, due to inadequate intake of precursors, such as 18:3,n-3, and higher intake of the 18:1,n-9 trans isomer leading to desaturase inhibition, and from an increased peroxidation of LCPUFA due to oxidative stress.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first lipidomic studies showed that individuals with moderate96 or severe97 obesity and MASLD had phospholipids rich in monounsaturated fatty acids (palmitoleic, oleic acid) and long-chain PUFAs (n-6:n-3 ratio, and n-6) compared with controls.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [97]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
Ohkawa, H., Ohishi, N., & Yagi, K. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90738-3 · Cited by 29,297
[38] Oxidative damage to proteins: Spectrophotometric method for carbonyl assay
Reznick, A. Z., & Packer, L. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33041-7 · Cited by 2,452
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Biochemistry of Oxidative Stress
Sies, H. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198610581 · Cited by 1,306
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Cytochrome P-4502E1: its physiological and pathological role
Lieber, C. S. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.2.517 · Cited by 889
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M. D., Farrell, G. C., Hall, P., Ingelman-Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 614
Burdge, G. C., Jones, A. E., & Wootton, S. A. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002662 · Cited by 598
Cited by
Items 101–200 of 703
He, X.-X., Wu, X.-L., Chen, R.-P., Chen, C., Liu, X.-G., Wu, B.-J., & Huang, Z.-M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162368 · Cited by 129
Musa-Veloso, K., Venditti, C., Lee, H. Y., Darch, M., Floyd, S., West, S., & Simon, R. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy022 · Cited by 123
Decreased Liver Fatty Acid Δ‐6 and Δ‐5 Desaturase Activity in Obese Patients
Araya, J., Rodrigo, R., Pettinelli, P., Araya, A. V., Poniachik, J., & Videla, L. A. (2010) · Obesity · doi:10.1038/oby.2009.379 · Cited by 125
Self-citationNogueira, M. A., de Oliveira, C. P. M. S., Alves, V. A. F., Stefano, J. T., Rodrigues, L., Torrinhas, R. S., Cogliati, B., Barbeiro, H. V., Carrilho, F. J., & Waitzberg, D. L. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.05.001 · Cited by 132
Ortiz, M., Soto-Alarcón, S. A., Orellana, P., Espinosa, A., Campos, C., López-Arana, S., Rincón, M. A., Illesca, P., Valenzuela, R., & Videla, L. A. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.04.019 · Cited by 123
Self-citationMechanisms and clinical implications of hepatocyte lipoapoptosis
Cazanave, S. C., & Gores, G. J. (2010) · Clinical Lipidology · doi:10.2217/clp.09.85 · Cited by 122
Wang, L.-F., Wang, X.-N., Huang, C.-C., Hu, L., Xiao, Y.-F., Guan, X.-H., Qian, Y.-S., Deng, K.-Y., & Xin, H.-B. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0464-z · Cited by 124
Feng, R., Luo, C., Li, C., Du, S., Okekunle, A. P., Li, Y., Chen, Y., Zi, T., & Niu, Y. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0551-1 · Cited by 120
Long-Term Adult Feline Liver Organoid Cultures for Disease Modeling of Hepatic Steatosis
Kruitwagen, H. S., Oosterhoff, L. A., Vernooij, I. G. W. H., Schrall, I. M., van Wolferen, M. E., Bannink, F., Roesch, C., van Uden, L., Molenaar, M. R., Helms, J. B., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.02.015 · Cited by 111
Maslak, E., Gregorius, A., & Chlopicki, S. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.04.010 · Cited by 112
Sztolsztener, K., Chabowski, A., Harasim‐Symbor, E., Bielawiec, P., & Konstantynowicz-Nowicka, K. (2020) · Biomolecules · doi:10.3390/biom10081133 · Cited by 124
Polyunsaturated Fatty Acid Pattern in Liver and Erythrocyte Phospholipids from Obese Patients
Elizondo, A., Araya, J., Rodrigo, R., Poniachik, J., Csendes, A., Maluenda, F., Díaz, J. C., Signorini, C., Sgherri, C., Comporti, M., et al. (2007) · Obesity · doi:10.1038/oby.2007.518 · Cited by 114
Self-citationThe therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease
Shapiro, H., Tehilla, M., Attal-Singer, J., Bruck, R., Luzzatti, R., & Singer, P. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.06.001 · Cited by 122
El‐Badry, A. M., Moritz, W., Contaldo, C., Tian, Y., Graf, R., & Clavien, P. (2007) · Hepatology · doi:10.1002/hep.21625 · Cited by 114
Eslamparast, T., Tandon, P., & Raman, M. (2017) · Nutrients · doi:10.3390/nu9080800 · Cited by 108
Echeverría, F., Valenzuela, R., Espinosa, A., Bustamante, A., Álvarez, D., Gonzalez‐Mañán, D., Ortíz, M., Soto-Alarcón, S. A., & Videla, L. A. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.09.012 · Cited by 113
Self-citationAl-Rejaie, S. S., Aleisa, A. M., Sayed‐Ahmed, M. M., Al‐Shabanah, O. A., Abuohashish, H. M., Ahmed, M. M., Alhosaini, K. A., & Hafez, M. M. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-136 · Cited by 109
Santoro, N., Savoye, M., Kim, G., Marotto, K., Shaw, M. M., Pierpont, B., & Caprio, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037827 · Cited by 108
Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity
Walle, P., Takkunen, M. J., Männistö, V., Vaittinen, M., Lankinen, M. A., Kärjä, V. J., Käkelä, P., Ågren, J., Tiainen, M., Schwab, U., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2016.01.011 · Cited by 115
Valenzuela, R., Espinosa, A., González-Mañán, D., D'Espessailles, A., Fernández, V., Videla, L. A., & Tapia, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046400 · Cited by 106
Self-citationHepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia
Sankatsing, R. R., Fouchier, S. W., de Haan, S., Hutten, B. A., de Groot, E., Kastelein, J. J. P., & Stroes, E. S. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176191.64314.07 · Cited by 106
Lipidomics Biomarkers of Diet-Induced Hyperlipidemia and Its Treatment with Poria cocos
Miao, H., Zhao, Y., Vaziri, N. D., Tang, D., Chen, H., Chen, H., Khazaeli, M., Boldaji, M. T., Hatami, L., & Zhao, Y. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b05350 · Cited by 106
Shang, T., Liu, L., Zhou, J., Zhang, M., Hu, Q., Fang, M., Wu, Y., Yao, P., & Gong, Z. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0461-2 · Cited by 111
Valenzuela, R., Echeverría, F., Ortíz, M., Rincón‐Cervera, M. Á., Espinosa, A., Hernández‐Rodas, M. C., Illesca, P., Valenzuela, A., & Videla, L. A. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0450-5 · Cited by 114
Self-citationde Meijer, V. E., Le, H. D., Meisel, J. A., Gura, K. M., & Puder, M. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181bbf51e · Cited by 106
Ditzel, E. J., Nguyen, T. Y. T., Parker, P., & Camenisch, T. D. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1409501 · Cited by 110
Liver NF‐κB and AP‐1 DNA Binding in Obese Patients
Videla, L. A., Tapia, G., Rodrigo, R., Pettinelli, P., Haim, D., Santibáñez, C., Araya, A. V., Smok, G., Csendes, A., Gutiérrez, L., et al. (2009) · Obesity · doi:10.1038/oby.2008.601 · Cited by 116
Self-citationPachikian, B. D., Essaghir, A., Demoulin, J., Catry, E., Neyrinck, A. M., Dewulf, E. M., Sohet, F. M., Portois, L., Clerbaux, L., Carpentier, Y. A., et al. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200364 · Cited by 98
Song, X., Wang, J., Wang, P., Tian, N., Yang, M., & Kong, L. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.02.014 · Cited by 100
Byrne, C. D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03732.x · Cited by 95
Intravenous Lipid Emulsions in Parenteral Nutrition
Fell, G. L., Nandivada, P., Gura, K. M., & Puder, M. (2015) · Advances in Nutrition · doi:10.3945/an.115.009084 · Cited by 109
Bravo, E., Palleschi, S., Aspichueta, P., Buqué, X., Rossi, B., Cano, A., Napolitano, M., Ochoa, B., & Botham, K. M. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-60 · Cited by 96
Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats
Hussein, O. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i3.361 · Cited by 93
Lau, L. H. S., & Wong, S. H. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_9 · Cited by 104
Videla, L. A., & Valenzuela, R. (2021) · BioFactors · doi:10.1002/biof.1797 · Cited by 96
Self-citationMapping the double bonds in triglycerides
Bydder, M., Girard, O. M., & Hamilton, G. (2011) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2011.07.004 · Cited by 96
Pachikian, B. D., Essaghir, A., Demoulin, J., Neyrinck, A. M., Catry, É., Backer, F. C. D., Dejeans, N., Dewulf, E. M., Sohet, F. M., Portois, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023365 · Cited by 96
Valenzuela, R., Barrera, C. R., Espinosa, A., Llanos, P., Orellana, P., & Videla, L. A. (2015) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2015.04.002 · Cited by 97
Self-citationPeleman, C., Francque, S., & Berghe, T. V. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105088 · Cited by 100
Role of pancreatic fat in the outcomes of pancreatitis
Acharya, C., Navina, S., & Singh, V. P. (2014) · Pancreatology · doi:10.1016/j.pan.2014.06.004 · Cited by 91
Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis
Wattacheril, J., Seeley, E. H., Angel, P., Chen, H., Bowen, B. P., Lanciault, C., M.Caprioli, R., Abumrad, N., & Flynn, C. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057165 · Cited by 88
Prevention of parenteral nutrition-associated liver disease: role of ω-3 fish oil
Fallon, E. M., Le, H. D., & Puder, M. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283394879 · Cited by 89
Echeverría, F., Valenzuela, R., Bustamante, A., Álvarez, D., Ortíz, M., Espinosa, A., Illesca, P., Gonzalez‐Mañán, D., & Videla, L. A. (2019) · Food & Function · doi:10.1039/c9fo01373c · Cited by 89
Self-citationOkada, K., Warabi, E., Sugimoto, H., Horie, M., Gotoh, N., Tokushige, K., Hashimoto, E., Utsunomiya, H., Takahashi, H., Ishii, T., et al. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0659-z · Cited by 92
Shin, S. M., & Kim, S. G. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051128 · Cited by 89
Mock, K., Lateef, S. S., Benedito, V. A., & Tou, J. C. L. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.09.010 · Cited by 99
Tapia, G., Valenzuela, R., Espinosa, A., Pamela Romanque, U., Dossi, C. G., Gonzalez‐Mañán, D., Videla, L. A., & D’Espessailles, A. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300458 · Cited by 94
Self-citationValtolina, C., & Favier, R. P. (2017) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2016.11.014 · Cited by 87
Long‐chain polyunsaturated fatty acid status in obesity: a systematic review and meta‐analysis
Fekete, K., Györei, E., Lohner, S., Verduci, E., Agostoni, C. V., & Decsi, T. (2015) · Obesity Reviews · doi:10.1111/obr.12280 · Cited by 99
Monteiro, J., Leslie, M., Moghadasian, M. H., Arendt, B. M., Allard, J. P., & Ma, D. W. L. (2014) · Food & Function · doi:10.1039/c3fo60551e · Cited by 82
Pathil, A., Mueller, J., Warth, A., Chamulitrat, W., & Stremmel, W. (2011) · Hepatology · doi:10.1002/hep.25531 · Cited by 87
Medaka as a model for human nonalcoholic steatohepatitis
Matsumoto, T., Terai, S., Oishi, T., Kuwashiro, S., Fujisawa, K., Yamamoto, N., Fujita, Y., Hamamoto, Y., Furutani‐Seiki, M., Nishina, H., et al. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.002311 · Cited by 89
Xie, C., Chen, Z., Zhang, C., Xu, X. Y., Jin, J., Zhan, W., Han, T., & Wang, J. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.06.001 · Cited by 87
Stiuso, P., Scognamiglio, I., Murolo, M., Ferranti, P., De Simone, C., Rizzo, M. R., Tuccillo, C., Caraglia, M., Loguercio, C., & Federico, A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/169216 · Cited by 82
Therapy of nonalcoholic fatty liver disease: current status.
Duvnjak, M., Tomašić, V., Gomerčić, M., Duvnjak, L. S., Baršić, N., & Lerotić, I. (2009) · PubMed · Cited by 90
Lv, Z., Xing, K., Li, G., Liu, D., & Guo, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01493 · Cited by 85
ORELLANA, M., RODRIGO, R., VARELA, N., ARAYA, J., PONIACHIK, J., CSENDES, A., SMOK, G., & VIDELA, L. (2006) · Hepatology Research · doi:10.1016/j.hepres.2005.10.001 · Cited by 78
Self-citationPNPLA3 expression and its impact on the liver: current perspectives
Bruschi, F. V., Tardelli, M., Claudel, T., & Trauner, M. (2017) · Hepatic Medicine: Evidence and Research · doi:10.2147/hmer.s125718 · Cited by 81
Ristic-Medic, D., Kovacic, M., Takic, M., Arsic, A., Petrovic, S., Paunovic, M., Jovicic, M., & Vucic, V. (2020) · Nutrients · doi:10.3390/nu13010015 · Cited by 81
“As n-3 PUFAs are precursors for anti-inflammatory eicosanoids, their dietaryinduced uprise diminishes hepatotoxic alternations in NAFLD [40].”
Backgroundω-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes
Hao, W., Wong, O. Y., Liu, X., Lee, P., Chen, Y., & Wong, K. K. Y. (2010) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2010.08.044 · Cited by 89
Guo, X., Yang, B., Tang, J., & Li, D. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.01.003 · Cited by 81
Xu, H., & Zhuang, X. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s208061 · Cited by 83
Videla, L. A., & Pettinelli, P. (2012) · PPAR Research · doi:10.1155/2012/107434 · Cited by 85
Self-citationScaglioni, F., Ciccia, S., Marino, M., Bedogni, G., & Bellentani, S. (2011) · Digestive Diseases · doi:10.1159/000323886 · Cited by 96
Miler, M., Živanović, J., Ajdžanović, V. Z., Oreščanin-Dušić, Z., Milenković, D., Konić‐Ristić, A., Blagojević, D. P., Milošević, V., & Šošić‐Jurjević, B. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.08.014 · Cited by 81
Fengler, V. H., Macheiner, T., Kessler, S. M., Czepukojc, B., Gemperlein, K., Müller, R., Kiemer, A. K., Magnes, C., Haybaeck, J., Lackner, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155163 · Cited by 84
Kawano, Y., Nishiumi, S., Tanaka, S., Nobutani, K., Miki, A., Yano, Y., Seo, Y., Kutsumi, H., Ashida, H., Azuma, T., et al. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.09.001 · Cited by 78
Non‐alcoholic fatty liver disease is associated with cardiovascular disease risk markers
Edens, M. A., Kuipers, F., & Stolk, R. P. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00594.x · Cited by 81
Burns, D. L., & Gill, B. M. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112450301 · Cited by 78
Non-alcoholic fatty liver disease in 2016
Townsend, S. A., & Newsome, P. N. (2016) · British Medical Bulletin · doi:10.1093/bmb/ldw031 · Cited by 74
Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease
Valenzuela, R., Ortíz, M., Hernández‐Rodas, M. C., Echeverría, F., & Videla, L. A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190410121716 · Cited by 77
Self-citationBargut, T. C. L., Frantz, E. D. C., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2014) · Lipids · doi:10.1007/s11745-014-3892-9 · Cited by 85
Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
Pettinelli, P., Obregón, A. M., & Videla, L. A. (2011) · PubMed · doi:10.1590/s0212-16112011000300003 · Cited by 85
Self-citationPathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
Yoon, H., & Soo, B. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i11.800 · Cited by 83
Poníachik, J., Csendes, A., Díaz, J. C., Flores, J. R., Patricio Burdiles, P., Maluenda, F., Smok, G., Rodrigo, R., & Videla, L. A. (2006) · Cytokine · doi:10.1016/j.cyto.2006.02.006 · Cited by 80
Self-citationNutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
Conlon, B., Beasley, J., Aebersold, K., Jhangiani, S., & Wylie-Rosett, J. (2013) · Nutrients · doi:10.3390/nu5104093 · Cited by 72
Lee, M. R., Yang, H. J., Park, K., & Yeul, J. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.07.008 · Cited by 77
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Wang, X., Cao, Y., Fu, Y., Guo, G., & Zhang, X. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-234 · Cited by 85
Vilar-Gomez, E., Pirola, C. J., Sookoian, S., Wilson, L. A., Belt, P., Liang, T., Liu, W., & Chalasani, N. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001072 · Cited by 68
Long‐TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat
Lundbom, J., Hakkarainen, A., Söderlund, S., Westerbacka, J., Lundbom, N., & Taskinen, M. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1580 · Cited by 70
Fatty liver induced by free radicals and lipid peroxidation
Morita, M., Ishida, N., Uchiyama, K., Yamaguchi, K., Itoh, Y., Shichiri, M., Yoshida, Y., Hagihara, Y., Naito, Y., Yoshikawa, T., et al. (2012) · Free Radical Research · doi:10.3109/10715762.2012.677840 · Cited by 77
Mitochondrial adaptation in steatotic mice
Einer, C., Hohenester, S., Wimmer, R., Wottke, L., Artmann, R., Schulz, S., Gosmann, C., Simmons, A., Leitzinger, C., Eberhagen, C., et al. (2018) · Mitochondrion · doi:10.1016/j.mito.2017.08.015 · Cited by 72
“2B left panels), in agreement with findings in NAFLD patients (Araya et al., 2004; Puri et al., 2007).”
Implications of diet on nonalcoholic fatty liver disease
Sullivan, S. A. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283358a58 · Cited by 83
Kajikawa, S., Harada, T., Kawashima, A., Imada, K., & Mizuguchi, K. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.02.004 · Cited by 77
Musazadeh, V., Roshanravan, N., Dehghan, P., & Ahrabi, S. S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.844242 · Cited by 78
A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD
Hossain, N., Kanwar, P., & Mohanty, S. R. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/7109270 · Cited by 75
Lee, S. I., Valim, C., Johnston, P. R., Le, H. D., Meisel, J. A., Arsenault, D. A., Gura, K. M., & Puder, M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181bbdf2b · Cited by 69
Morisco, F., Vitaglione, P., Amoruso, D., Russo, B., Fogliano, V., & Caporaso, N. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.003 · Cited by 67
Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies
Nseir, W., Mograbi, J., & Ghali, M. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2118-3 · Cited by 70
Stearoyl-CoA Desaturase: A Vital Checkpoint in the Development and Progression of Obesity
Poudyal, H., & Brown, L. (2011) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153011796429826 · Cited by 76
Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles
Vesterdal, L. K., Danielsen, P. H., Folkmann, J. K., Jespersen, L. F., Aguilar-Pelaez, K., Roursgaard, M., Loft, S. H., & Möller, P. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.001 · Cited by 67
Zhang, D., Zhang, J., Wu, X., Liu, Y., Gu, S., Zhu, G., Wang, Y.-Z., Gao-lin, L., & Li, X. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00238 · Cited by 66
Parafati, M., Kirby, R. J., Khorasanizadeh, S., Rastinejad, F., & Malany, S. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033530 · Cited by 60
Zhang, T., Yamamoto, N., & Ashida, H. (2014) · Food & Function · doi:10.1039/c3fo60694e · Cited by 64
Direct effects of iodothyronines on excess fat storage in rat hepatocytes
Grasselli, E., Voci, A., Canesi, L., Matteis, R. D., Goglia, F., Cioffi, F., Fugassa, E., Gallo, G., & Vergani, L. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.027 · Cited by 66
Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis
Vergani, L. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170518101334 · Cited by 65
The role of hepatic lipid composition in obesity‐related metabolic disease
Willis, S. A., Bawden, S., Malaikah, S., Sargeant, J. A., Stensel, D. J., Aithal, G. P., & King, J. A. (2021) · Liver International · doi:10.1111/liv.15059 · Cited by 69
Nonalcoholic Fatty Liver Disease and Omega-3 Fatty Acids: Mechanisms and Clinical Use
Spooner, M. H., & Jump, D. Β. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061021-030223 · Cited by 64
PTP1B inhibitor improves both insulin resistance and lipid abnormalities in vivo and in vitro
Ma, Y.-M., Tao, R.-Y., Liu, Q., Li, J., Tian, J.-Y., Zhang, X.-L., Xiao, Z.-Y., & Ye, F. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0876-4 · Cited by 62
Liao, C., Ou, T., Huang, H., & Wang, C. (2013) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6386 · Cited by 66
Metadata
- Authors
- ARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J.
- Affiliations
- Departamento de Nutrición, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Casilla 70058, Santiago 7, Santiago, Chile
- University of Chile (CL)
- Programa de Farmacología Molecular y Clínica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Casilla 70058, Santiago 7, Santiago, Chile
- Servicio de Gastroenterología, Hospital Clínico de la Universidad de Chile, Casilla 70058, Santiago 7, Santiago, Chile
- Corresponding author
- PETTINELLI, Paulina
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2004-06-01
- Volume
- 106
- Issue
- 6
- Pages
- 635-643
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2072721395
- Cited by
- 700
- References
- 46
- Citations by year
- 2026: 12 · 2025: 27 · 2024: 25 · 2023: 26 · 2022: 31 · 2021: 42 · 2020: 56 · 2019: 43 · 2018: 34 · 2017: 46 · 2016: 41 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 40
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- green
- americanae.aecid.es
- Licence
- other-oa
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- non-alcoholic fatty liver disease, hepatic steatosis, long-chain polyunsaturated fatty acids, n-6/n-3 ratio, hepatic triglycerides, hepatic phospholipids, adipose tissue fatty acids, trans fatty acids, lipid peroxidation, oxidative stress, protein carbonylation, malondialdehyde, fatty acid desaturation
- MeSH terms
- Adipose Tissue, Adult, Fatty Acids, Unsaturated, Fatty Liver, Humans, Lipids, Liver, Middle Aged, Phospholipids, Triglycerides, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.